288
Views
20
CrossRef citations to date
0
Altmetric
Original Article: Research

Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival

, , , , &
Pages 134-148 | Received 30 Mar 2007, Accepted 20 Jul 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hee-Sun Hwang, A-Reum Han, Ji Yoon Lee, Gyeong Sin Park, Woo-Sung Min & Hee-Je Kim. (2019) Enhanced Anti-Leukemic Effects through Induction of Immunomodulating Microenvironment by Blocking CXCR4 and PD-L1 in an AML Mouse Model. Immunological Investigations 48:1, pages 96-105.
Read now
Dorothy A. Sipkins. (2008) Chemotherapy and the bone marrow stroma. Leukemia & Lymphoma 49:1, pages 17-18.
Read now

Articles from other publishers (18)

Cristian Sandoval, Yolanda Calle, Karina Godoy & Jorge Farías. (2023) An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment. International Journal of Molecular Sciences 24:7, pages 6031.
Crossref
Christopher Hino, Bryan Pham, Daniel Park, Chieh Yang, Michael H.K. Nguyen, Simmer Kaur, Mark E. Reeves, Yi Xu, Kevin Nishino, Lu Pu, Sue Min Kwon, Jiang F. Zhong, Ke K. Zhang, Linglin Xie, Esther G. Chong, Chien-Shing Chen, Vinh Nguyen, Dan Ran Castillo & Huynh Cao. (2022) Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products. Biomedicines 10:6, pages 1410.
Crossref
Liana E Gynn, Elizabeth Anderson, Gareth Robinson, Sarah A Wexler, Gillian Upstill-Goddard, Christine Cox & Jennifer E May. (2021) Primary mesenchymal stromal cells in co-culture with leukaemic HL-60 cells are sensitised to cytarabine-induced genotoxicity, while leukaemic cells are protected. Mutagenesis 36:6, pages 419-428.
Crossref
Jie Shen, Zhiguo Lu, Jianze Wang, Tianlu Zhang, Jun Yang, Yan Li, Guiying Liu & Xin Zhang. (2020) Advances of Nanoparticles for Leukemia Treatment. ACS Biomaterials Science & Engineering 6:12, pages 6478-6489.
Crossref
Zhenshu Xu, Donglian Xiong, Jushun Zhang, Jingyan Zhang, Xiuli Chen, Zhizhe Chen & Rong Zhan. (2017) Bone marrow stromal cells enhance the survival of chronic lymphocytic leukemia cells by regulating HES‑1 gene expression and H3K27me3 demethylation. Oncology Letters.
Crossref
Wenwen Wang, Tilmann Bochtler, Patrick Wuchter, Linda Manta, Haiju He, Volker Eckstein, Anthony D. Ho & Christoph Lutz. (2017) Mesenchymal stromal cells contribute to quiescence of therapy-resistant leukemic cells in acute myeloid leukemia. European Journal of Haematology 99:5, pages 392-398.
Crossref
D. Sá da Bandeira, J. Casamitjana & M. Crisan. (2017) Pericytes, integral components of adult hematopoietic stem cell niches. Pharmacology & Therapeutics 171, pages 104-113.
Crossref
Emyr Bakker, Malak Qattan, Luciano Mutti, Constantinos Demonacos & Marija Krstic-Demonacos. (2016) The role of microenvironment and immunity in drug response in leukemia. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:3, pages 414-426.
Crossref
A-REUM HAN, JI YOON LEE, HEE-JE KIM, WOO-SUNG MIN, GYEONGSIN PARK & SE-HOON KIM. (2015) A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment. Oncology Reports 34:6, pages 2880-2888.
Crossref
Alberta Bergamo & Gianni Sava. (2015) Linking the future of anticancer metal-complexes to the therapy of tumour metastases. Chemical Society Reviews 44:24, pages 8818-8835.
Crossref
YUXIANG HAN, YING WANG, ZHENG XU, JIE LI, JINGCI YANG, YAN LI, YINTAO SHANG & JIANMIN LUO. (2013) Effect of bone marrow mesenchymal stem cells from blastic phase chronic myelogenous leukemia on the growth and apoptosis of leukemia cells. Oncology Reports 30:2, pages 1007-1013.
Crossref
Douglas W. McMillin, Joseph M. Negri & Constantine S. Mitsiades. (2013) The role of tumour–stromal interactions in modifying drug response: challenges and opportunities. Nature Reviews Drug Discovery 12:3, pages 217-228.
Crossref
Sucheta Jagan, Laura A. Paganessi, Robin R. Frank, Parameswaran Venugopal, Melissa Larson & Kent W. Christopherson. (2012) Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine. Advances in Hematology 2012, pages 1-12.
Crossref
Ilaria E. Palamà, Stefania D'Amone, Addolorata M. L. Coluccia, Mariano Biasiucci & Giuseppe Gigli. (2012) Cell self-patterning on uniform PDMS-surfaces with controlled mechanical cues. Integr. Biol. 4:2, pages 228-236.
Crossref
Luis A. Crespo, Xinwei Zhang & Jianguo Tao. 2011. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures 215 233 .
F Ayala, R Dewar, M Kieran & R Kalluri. (2009) Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 23:12, pages 2233-2241.
Crossref
Mark B. Meads, Robert A. Gatenby & William S. Dalton. (2009) Environment-mediated drug resistance: a major contributor to minimal residual disease. Nature Reviews Cancer 9:9, pages 665-674.
Crossref
Danielle N. Yarde & Jianguo Tao. 2009. Apoptosis in Carcinogenesis and Chemotherapy. Apoptosis in Carcinogenesis and Chemotherapy 193 218 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.